News | April 22, 2026
Zyax Chem takes 26% stake in Gaymed Labs
Targets high-growth eye care expansion push
Targets high-growth eye care expansion push
Divestment marks Redcliffe’s strategic pivot toward preventive and advanced diagnostics; Crysta IVF to continue under existing leadership
Capital infusion to accelerate Earendil’s R&D platform
The new solution combines Watchmaker Genomics’ high-performance NGS chemistry with Volta’s digital fluidics platform
This multi-year CDMO agreement involves significant, ongoing manufacturing for a global pharmaceutical major
The agreement will see the two companies jointly develop and commercialise premium nutraceutical ingredients in advanced transdermal delivery formats
The enhancements will improve environmental sustainability, strengthen material governance, and boost utility reliability
The company recorded consolidated revenue of Rs. 660 crore in Q3 FY26, up
The company reported Q3 total income of Rs. 1,005 million, marking a 10.2% increase year-on-year
Laurus Labs has reported total income of Rs. 1,784.05 crore during the period ended December 31, 2025
Subscribe To Our Newsletter & Stay Updated
